Moreover, preventing CD80 expression on MDSC or the use of anti-CTLA-4 antibodies delay tumor growth, suggesting that CTLA-4/CD80 interaction between MDSC and Treg is necessary for their activity or their development (Yang et al., 2006). The gene discussed is CTLA4; the disease is neoplasm.